, 50:109 | Cite as

Current status of transcriptional regulation systems

  • Tobias May
  • Hansjörg HauserEmail author
  • Dagmar Wirth
original Paper


Many attempts have been undertaken to control transgene activity in mammalian cells. This is of importance for both applied biotechnology and basic research activities. State of the art regulatory systems use elements for transgene regulation which are unrelated to host regulatory networks and thus do not interfere with endogenous activities. Most of these regulation systems consist of transregulators and transregulator responding promoter elements that are derived from non mammalian origin. Apart from the tetracycline (Tet) regulated system which is most widely used for conditional gene expression at the moment, a number of new systems were created. These systems have been significantly refined and their performance makes them suitable for regulating transgenes not only in cellular systems but also in transgenic animals and for human therapeutic use.


Viral transduction Autoregulatory expression Test-system Synthetic promotor Gene regulation 



 Enhanced green fluorescent protein


 Recombinant human erythropoietin


 Gene of interest


 Internal ribosomal entry site


 Low molecular weight


 Polyadenylation site


 Transactivator dependent promoter


 Secreted form of human placental alkaline phosphatase


 Simian virus 40 large T antigen


  1. Agha-Mohammadi S, O’Malley M, Etemad A, Wang Z, Xiao X, Lotze MT (2004) Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817–828CrossRefGoogle Scholar
  2. Akagi K, Kanai M, Saya H, Kozu T, Berns A (2001) A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res 29:E23CrossRefGoogle Scholar
  3. Baron U, Freundlieb S, Gossen M, Bujard H (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605–3606CrossRefGoogle Scholar
  4. Baron U, Gossen M, Bujard H (1997) Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25:2723–2729CrossRefGoogle Scholar
  5. Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W, Bujard H (1999) Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci USA 96:1013–1018CrossRefGoogle Scholar
  6. Becskei A, Seraphin B, Serrano L (2001) Positive feedback in eukaryotic gene networks: cell differentiation by graded to binary response conversion. EMBO J 20:2528–2535CrossRefGoogle Scholar
  7. Biggar SR, Crabtree GR (2001) Cell signaling can direct either binary or graded transcriptional responses. EMBO J 20:3167–3176CrossRefGoogle Scholar
  8. Boorsma M, Nieba L, Koller D, Bachmann MF, Bailey JE, Renner WA (2000) A temperature-regulated replicon-based DNA expression system. Nat Biotechnol 18:429–432CrossRefGoogle Scholar
  9. Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, Levivier M, Brotchi J, Velu T, Tenenbaum L (2003) Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther 10:84–94CrossRefGoogle Scholar
  10. Deuschle U, Meyer WK, Thiesen HJ (1995) Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 15:1907–1914Google Scholar
  11. Felsher DW, Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4:199–207CrossRefGoogle Scholar
  12. Fitzsimons HL, Mckenzie JM, During MJ (2001) Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 8:1675–1681CrossRefGoogle Scholar
  13. Freundlieb S, Schirra-Muller C, Bujard H (1999) A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1:4–12CrossRefGoogle Scholar
  14. Fussenegger M (2001) The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 17:1–51CrossRefGoogle Scholar
  15. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18:1203–1208CrossRefGoogle Scholar
  16. Fussenegger M, Moser S, Mazur X, Bailey JE (1997) Autoregulated multicistronic expression vectors provide one-step cloning of regulated product gene expression in mammalian cells. Biotechnol Prog 13:733–740CrossRefGoogle Scholar
  17. Fux C, Weber W, Daoud-el Baba M, Heinzen C, Aubel D, Fussenegger M (2003) Novel macrolide-adjustable bidirectional expression modules for coordinated expression of two different transgenes in mice. J Gene Med 5:1067–1079CrossRefGoogle Scholar
  18. Gill G, Ptashne M (1988) Negative effect of the transcriptional activator GAL4. Nature 334:721–724CrossRefGoogle Scholar
  19. Gonzalez-Nicolini V, Fussenegger M (2005) A novel binary adenovirus-based dual-regulated expression system for independent transcription control of two different transgenes. J Gene Med 7:1573–1585CrossRefGoogle Scholar
  20. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551CrossRefGoogle Scholar
  21. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766–1769CrossRefGoogle Scholar
  22. Gould DJ, Chernajovsky Y (2004) Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline system. Mol Ther 10:127–138CrossRefGoogle Scholar
  23. Hartenbach S, Fussenegger M (2005) Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J Biotechnol 120:83–98CrossRefGoogle Scholar
  24. Hennecke M, Kwissa M, Metzger K, Oumard A, Kroger A, Schirmbeck R, Reimann J, Hauser H (2001) Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 29:3327–3334CrossRefGoogle Scholar
  25. Hoang T (2004) The origin of hematopoietic cell type diversity. Oncogene 23:7188–7198CrossRefGoogle Scholar
  26. Hofmann A, Nolan GP, Blau HM (1996) Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 93:5185–5190CrossRefGoogle Scholar
  27. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C (1995) The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 270:14168–14174CrossRefGoogle Scholar
  28. Hu MC, Davidson N (1987) The inducible lac operator–repressor system is functional in mammalian cells. Cell 48:555–566CrossRefGoogle Scholar
  29. Hwang JJ, Scuric Z, Anderson WF (1996) Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol 70:8138–8141Google Scholar
  30. Iida A, Chen ST, Friedmann T, Yee JK (1996) Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol 70:6054–6059Google Scholar
  31. Imhof MO, Chatellard P, Mermod N (2000) A regulatory network for the efficient control of transgene expression. J Gene Med 2:107–116CrossRefGoogle Scholar
  32. Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW (2002) Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297:102–104CrossRefGoogle Scholar
  33. Jiang L, Rampalli S, George D, Press C, Bremer EG, O’Gorman MR, Bohn MC (2004) Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Gene Ther 11:1057–1067CrossRefGoogle Scholar
  34. Joers A, Jaks V, Kase J, Maimets T (2004) p53-dependent transcription can exhibit both on/off and graded response after genotoxic stress. Oncogene 23:6175–6185CrossRefGoogle Scholar
  35. Kaern M, Elston TC, Blake WJ, Collins JJ (2005) Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 6:451–464CrossRefGoogle Scholar
  36. Kafri T, van Praag H, Gage FH, Verma IM (2000) Lentiviral vectors: regulated gene expression. Mol Ther 1:516–521CrossRefGoogle Scholar
  37. Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H, Yla-Herttuala S (2003) Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther 10:459–466CrossRefGoogle Scholar
  38. Kramer BP, Fussenegger M (2005) Hysteresis in a synthetic mammalian gene network. Proc Natl Acad Sci USA 102:9517–9522CrossRefGoogle Scholar
  39. Kramer BP, Viretta AU, Daoud-El-Baba M, Aubel D, Weber W, Fussenegger M (2004) An engineered epigenetic transgene switch in mammalian cells. Nat Biotechnol 22:867–870CrossRefGoogle Scholar
  40. Kringstein AM, Rossi FM, Hofmann A, Blau HM (1998) Graded transcriptional response to different concentrations of a single transactivator. Proc Natl Acad Sci USA 95:13670–13675CrossRefGoogle Scholar
  41. Kroger A, Dallugge A, Kirchhoff S, Hauser H (2003) IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo. Oncogene 22:1045–1056CrossRefGoogle Scholar
  42. Kues WA, Schwinzer R, Wirth D, Verhoeyen E, Lemme E, Herrmann D, Barg-Kues B, Hauser H, Wonigeit K, Niemann H (2006) Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double transgenic pigs. Faseb J (in press)Google Scholar
  43. Kuhnel F, Fritsch C, Krause S, Mundt B, Wirth T, Paul Y, Malek NP, Zender L, Manns MP, Kubicka S (2004) Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells. Nucleic Acids Res 32:e30CrossRefGoogle Scholar
  44. Kwissa M, Unsinger J, Schirmbeck R, Hauser H, Reimann J (2000) Polyvalent DNA vaccines with bidirectional promoters. J Mol Med 78:495–506CrossRefGoogle Scholar
  45. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36:147–150CrossRefGoogle Scholar
  46. Magee JA, Abdulkadir SA, Milbrandt J (2003) Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 3:273–283CrossRefGoogle Scholar
  47. Malphettes L, Weber CC, El Baba MD, Schoenmakers RG, Aubel D, Weber W, Fussenegger M (2005) A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1. Nucleic Acids Res 33:e107CrossRefGoogle Scholar
  48. Markusic D, Oude-Elferink R, Das AT, Berkhout B, Seppen J (2005) Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res 33:e63CrossRefGoogle Scholar
  49. May T, Hauser H, Wirth D (2004a) Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 32:5529–5538CrossRefGoogle Scholar
  50. May T, Lindenmaier W, Wirth D, Mueller PP (2004b) Application of a reversible immortalisation system for the generation of proliferation-controlled cell lines. Cytotechnology 46:69–78CrossRefGoogle Scholar
  51. May T, Wirth D, Hauser H, Mueller PP (2005a) Transcriptionally regulated immortalization overcomes side effects of temperature-sensitive SV40 large T antigen. Biochem Biophys Res Commun 327:734–741CrossRefGoogle Scholar
  52. May T, Mueller PP, Weich H, Froese N, Deutsch U, Wirth D, Kroger A, Hauser H (2005b) Establishment of murine cell lines by constitutive and conditional immortalization. J Biotechnol 120:99–110CrossRefGoogle Scholar
  53. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678–1683CrossRefGoogle Scholar
  54. Mitta B, Weber CC, Rimann M, Fussenegger M (2004) Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression. Nucleic Acids Res 32:e106CrossRefGoogle Scholar
  55. Mizuguchi H, Hayakawa T (2002) The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector. J␣Gene Med 4:240–247CrossRefGoogle Scholar
  56. Mizuguchi H, Xu ZL, Sakurai F, Mayumi T, Hayakawa T (2003) Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 14:1265–1277CrossRefGoogle Scholar
  57. No D, Yao TP, Evans RM (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93:3346–3351CrossRefGoogle Scholar
  58. Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA (1996) Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 70:62–67Google Scholar
  59. Rao CV, Wolf DM, Arkin AP (2002) Control, exploitation and tolerance of intracellular noise. Nature 420:231–237CrossRefGoogle Scholar
  60. Reiser J, Lai Z, Zhang XY, Brady RO (2000) Development of multigene and regulated lentivirus vectors. J Virol 74:10589–10599CrossRefGoogle Scholar
  61. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, Snyder RO (1998) Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 16:757–761CrossRefGoogle Scholar
  62. Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT, Blau HM (1998) Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 20:389–393CrossRefGoogle Scholar
  63. Rossi FM, Kringstein AM, Spicher A, Guicherit OM, Blau HM (2000) Transcriptional control: rheostat converted to on/off switch. Mol Cell 6:723–728CrossRefGoogle Scholar
  64. Saam JR, Gordon JI (1999) Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem 274:38071–38082CrossRefGoogle Scholar
  65. Shockett P, Difilippantonio M, Hellman N, Schatz DG (1995) A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 92:6522–6526CrossRefGoogle Scholar
  66. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR (1993) Controlling signal transduction with synthetic ligands. Science 262:1019–1024CrossRefGoogle Scholar
  67. Spitzer D, Dittmar KE, Rohde M, Hauser H, Wirth D (2003) Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions. J Virol 77:6070–6075CrossRefGoogle Scholar
  68. Strathdee CA, McLeod MR, Hall JR (1999) Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 229:21–29CrossRefGoogle Scholar
  69. Tietge UJ, Kozarsky KF, Donahee MH, Rader DJ (2003) A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver. J Gene Med 5:567–575CrossRefGoogle Scholar
  70. Unsinger J, Kroger A, Hauser H, Wirth D (2001) Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes. Mol Ther 4:484–489CrossRefGoogle Scholar
  71. Unsinger J, Lindenmaier W, May T, Hauser H, Wirth D (2004) Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer. Biochem Biophys Res Commun 319:879–887CrossRefGoogle Scholar
  72. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000a) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963–7968CrossRefGoogle Scholar
  73. Urlinger S, Helbl V, Guthmann J, Pook E, Grimm S, Hillen W (2000b) The p65 domain from NF-kappaB is an efficient human activator in the tetracycline-regulatable gene expression system. Gene 247:103–110CrossRefGoogle Scholar
  74. Vigna E, Cavalieri S, Ailles L, Geuna M, Loew R, Bujard H, Naldini L (2002) Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther 5:252–261CrossRefGoogle Scholar
  75. Wang Y, O’Malley BW Jr, Tsai SY, O’Malley BW (1994) A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 91:8180–8184CrossRefGoogle Scholar
  76. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M (2002) Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 20:901–907CrossRefGoogle Scholar
  77. Weber W, Marty RR, Link N, Ehrbar M, Keller B, Weber CC, Zisch AH, Heinzen C, Djonov V, Fussenegger M (2003) Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system. Nucleic Acids Res 31:e69CrossRefGoogle Scholar
  78. Weber W, Rimann M, Spielmann M, Keller B, Daoud-el Baba M, Aubel D, Weber CC, Fussenegger M (2004) Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22:1440–1444CrossRefGoogle Scholar
  79. Xu ZL, Mizuguchi H, Mayumi T, Hayakawa T (2003) Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene 309:145–151CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  1. 1.Department of Gene Regulation and DifferentiationGBF—German Research Center for BiotechnologyBraunschweigGermany

Personalised recommendations